WallStreetZenWallStreetZen

NASDAQ: ONC
Beone Medicines Ltd Stock Ownership - Who owns Beone Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Beone Medicines Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John OylerChief Executive Officer2026-06-161,650$264.87
$437.04kSell
Chan Henry LeeSVP General Counsel2026-06-16590$265.98
$156.93kSell
Lai WangPresident Global Head of RD2026-06-161,169$265.39
$310.24kSell
Xiaobin WuPresident and COO2026-06-161,357$266.76
$362.00kSell
John OylerChief Executive Officer2026-06-16333$266.70
$88.81kSell
John OylerChief Executive Officer2026-06-161,710$265.99
$454.84kSell
Titus B. BallPrincipal Accounting Officer2026-06-11120$257.53
$30.90kSell
Aaron RosenbergChief Financial Officer2026-06-11631$257.74
$162.64kSell
Chan Henry LeeSVP General Counsel2026-06-11428$257.64
$110.27kSell
Xiaobin WuPresident and COO2026-06-11626$261.20
$163.51kSell

1 of 18

ONC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONC insiders and whales buy or sell their stock.

ONC Shareholders

What type of owners hold Beone Medicines Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hillhouse Capital Advisors Ltd10.17%147,035,258$39.72BInsider
Hhlr Advisors Ltd8.65%125,045,741$33.78BInsider
Hillhouse Capital Management Ltd7.67%110,866,146$29.95BInsider
Cb Biotech Investment Ltd1.36%19,601,138$5.30BInsider
Amgen Inc1.31%18,943,802$5.12BInsider
Baker Bros Advisors LP0.61%8,799,053$2.38BInstitution
Baker Bros Advisors LP0.56%8,078,829$2.18BInsider
Merck Co Inc0.55%7,942,314$2.15BInsider
John Oyler0.40%5,751,828$1.55BInsider
Xiaodong Wang0.38%5,491,395$1.48BInsider

1 of 3

ONC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONC2.41%31.95%Net SellingNet Selling
RPRX62.11%17.32%Net SellingNet Selling
RVMD91.09%8.91%Net SellingNet Selling
MRNA77.60%22.40%Net BuyingNet Selling
ALNY82.21%17.79%Net SellingNet Buying
View Top Biotech Stocks

Beone Medicines Stock Ownership FAQ

Who owns Beone Medicines?

Beone Medicines (NASDAQ: ONC) is owned by 2.41% institutional shareholders, 31.95% Beone Medicines insiders, and 65.64% retail investors. Hillhouse Capital Advisors Ltd is the largest individual Beone Medicines shareholder, owning 147.04M shares representing 10.17% of the company. Hillhouse Capital Advisors Ltd's Beone Medicines shares are currently valued at $39.72B.

If you're new to stock investing, here's how to buy Beone Medicines stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.